Member Info for spike912

ALLNothing I am invested so please do not make assumptions about my investment here, you have little right to do so. The RNS is vague and just seems they don’t have a clue what is going on, and us PI’s are sitting in the dark SPECULATING. My motive....clarity from what appears a board who seem rather incompetent given they have a matter of weeks to agree something yet after all this time remain with no deal from hudosn, nothing shipped, no strategic partner and only “tentative discussions” with their parties which were supposedly at “detailed discussions”...so what’s going on I have emailed the company for clarity

Where have Hudson requested board changes? I can’t see this anywhere?

“ I do not underestimate the challenge facing a company which as yet has no secure revenue stream. But there is demonstrable albeit tentative third-party interest“ According to the investor call they were in “detailed discussions”...why now only “tentative”? As I have said before this is getting far to tight to the wire for my liking if any success is they are still only having “tentative” talks some 2 weeks before they run out of cash.

Out

So confirm BH were one of the “super majors”

Concomitant corticosteroid treatment had a significant impact on mortality in the Traumakine treatment group. Mortality was 10.6% (7/66) for those receiving Traumakine and not on corticosteroids, versus 39.7% (31/78) for those receiving Traumakine and on concomitant corticosteroids. I think the 90% is rather statistically simplified if you read the entire Traumakine results over the last year and compare natural mortality rates Either way it’s postive but i think we would be somewhat higher than 75p if it was a simple 90% slam dunk success. More work to do, but postive

I would imagine at £8+ this share was seriously over bought on potential whereas now the reality due to trial and test results is the value driver not simply potential, coupled with being over sold (likely)

Facts, the drug hasn’t officially failed, it’s being modified and re trialed of sorts which will take circa 3 months (up to). At that point we will know if it is officially failed or not. Re news Thursday, I don’t know why everyone is so hooked on this. Imo all news would have been given on the 22nd at the biggest and best venue with top personnel from around the world in attendance. Thursday is like a “road show” just getting word out and presenting to different people and differing networks. Don’t get me wrong I would be estatic for news but imo it’s not coming. The CEO made it clear the 22nd (not the 22nd and maybe a few more a couple weeks later)....there was silence which lends me to believe nothing is known and nothing new will be presented. I think people are looking through rose tinted glasses and wanting news and an instant recovery. The market has not been impressed and wanted results, not explanations, and in the current bear market only expceptional new will do. Do we expect everytime there is a presentation we will get material news and results? Come on guys and girls. You’ve been told results Q4 last week, any sooner it would not have been branded Q4 it would have been “weeks”. Japanese results no one knows but my gut instinct would have been if they knew them they would have probably held off and presented all collectively on Thursday coming to give a full rounded result and benefit to the sp. just my own opinion before I get shot down by certain individuals

Mid November as lee investor call, so circa 2 weeks maybe a bit more maybe a bit less depending on current cash burn

Jrjnr what’s your problem mate? Please look at your own posts before claiming others as “pointless”. Glass houses and all that. Or maybe you could let me know why you are so convinced we will have some more results Thursday or material price rocketing information? Or is this just fantasist speculation. Always open to discussion and fact based options but calling someone’s posts “pointless” for having, quite frankly, a very reasonable view is rather pathetic. Have a good evening

I don’t think it’s about positivity or negativity to be fair. But there’s some big ramping on here at the minute on personal speculation. We are where we are, more trials required, Japan results not with us (no one knows why they are late or results). So just switch off and come back end of the year. All the wishing and speculation and mindless ramping won’t change a thing ;-) if your a LTH you’ll be fine

Probably about as many as yours Tadpole ;-)

Lol it’s been all sells today! Really successful obviously.

I think your reading into things that aren’t there;-) but let’s see. Personally I would be amazed to have something extra so soon given where we are. Let’s see but I won’t be getting my hopes up

The presentation could just be the same as the one on the 22nd but to different people...no? I would imagine like most companies they will be “road showing” the results of the investigation to get word out. I can’t see much more to present on, and anything highly important would have been said in Paris given personnel present. Just my opinion

It’s speculation. This is why zaza needs to offer clarity, for all we know there are three majors but we only got a deal with one. I’m not saying that is the situation at all, but this is why the market reacts like it does with frr, all rns end up leaving more questions than answers. Hopefully zaza will do an interview this week to shed some light. If we are still talking to two further majors...wow

The problem is the lack of detail in the rns. Do we know if there are still 2 majors? Is BH the only major we did the deal with? Commercial details? Are we still talking to anyone else? Needs clarity for the market to really take note. This RNS won’t cut it imo, but another opportunity to get in cheap, still one of best on AIM imo if your willing to be patient

Back out in force ffs

Another RNS with more questions as answers as per usual

Dan1nat1, i would like to think so, but I suppose it comes down to when the issues were discovered, and when they were able to put them right, coupled with how far advanced the japan trails already were. Speculation I know, but I don’t think they would have had time to change as most patients would have been well through the trail by the point the investigators found the issue and how to correct it (of sorts). You would have liked to think we would have been told if the Japanese trials were being altered or extended. Not saying there’s an issue at all, end of the day T works, it’s juat nice to understand how the EU findings are reflected in the up and coming Japanese results